Therefore, we performed a nested case–control study within the prospective Women's Health Initiative Study (WHI) to investigate the association between baseline serum concentrations of sRAGE and adiponectin, leptin, MCP1, and PAI1 and incident pancreatic cancer risk. Here, ADIPOQ is linked to familial pancreatic carcinoma.